Pharmacodynamic effects of alpha-methyl dopa in hypertensive subjects
- 31 January 1964
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 67 (1), 32-38
- https://doi.org/10.1016/0002-8703(64)90395-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Hemodynamic Effects of Methyldopa (Aldomet®) at Rest and during Exercise in Patients with Arterial HypertensionActa Medica Scandinavica, 1962
- Decarboxylase inhibitors in the treatment of hypertension∗The American Journal of Cardiology, 1962
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- The Clinical Evaluation of Faulty Orthostatic MechanismsMedical Clinics of North America, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- DopadecarboxylaseThe Science of Nature, 1939
- Fermentativer Abbau von l-Dioxyphenylalanin (Dopa) durch NiereNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1938